These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31208965)

  • 21. Prevalence of Human Papillomavirus Genotypes Among Women With High-Grade Cervical Lesions in Beijing, China.
    Xiao M; Xu Q; Li H; Gao H; Bie Y; Zhang Z
    Medicine (Baltimore); 2016 Jan; 95(3):e2555. PubMed ID: 26817906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human papilloma virus infection of uterine cervix and spectrum of cervical pathology in human immunodeficiency virus/AIDS.
    Jain BB; Adhikary T; Sadhukhan PC; Nandi A
    J Cancer Res Ther; 2021; 17(6):1462-1467. PubMed ID: 34916378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human papillomavirus genotypes distribution by cervical cytologic status among women attending the General Hospital of Loandjili, Pointe-Noire, Southwest Congo (Brazzaville).
    Boumba LM; Qmichou Z; Mouallif M; Attaleb M; El Mzibri M; Hilali L; Donatien M; Ennaji MM
    J Med Virol; 2015 Oct; 87(10):1769-76. PubMed ID: 25963674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of high-risk HPV genotypes, categorised by their quadrivalent and nine-valent HPV vaccination coverage, and the genotype association with high-grade lesions.
    Paz-Zulueta M; Álvarez-Paredes L; Rodríguez Díaz JC; Parás-Bravo P; Andrada Becerra ME; Rodríguez Ingelmo JM; Ruiz García MM; Portilla J; Santibañez M
    BMC Cancer; 2018 Jan; 18(1):112. PubMed ID: 29382323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs.
    Zhao D; Zhang L; Xie F; Peng D; Wei J; Jiang L; Zhang S; Qi D
    BMC Cancer; 2020 Aug; 20(1):810. PubMed ID: 32847541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease.
    Gravitt PE; Kovacic MB; Herrero R; Schiffman M; Bratti C; Hildesheim A; Morales J; Alfaro M; Sherman ME; Wacholder S; Rodriguez AC; Burk RD
    Int J Cancer; 2007 Dec; 121(12):2787-93. PubMed ID: 17722112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type-dependent association between risk of cervical intraepithelial neoplasia and viral load of oncogenic human papillomavirus types other than types 16 and 18.
    Fu Xi L; Schiffman M; Ke Y; Hughes JP; Galloway DA; He Z; Hulbert A; Winer RL; Koutsky LA; Kiviat NB
    Int J Cancer; 2017 Apr; 140(8):1747-1756. PubMed ID: 28052328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of CIN3 or worse with persistence of 13 individual oncogenic HPV types.
    Sand FL; Munk C; Frederiksen K; Junge J; Iftner T; Dehlendorff C; Kjaer SK
    Int J Cancer; 2019 Apr; 144(8):1975-1982. PubMed ID: 30246864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada.
    Coutlée F; Ratnam S; Ramanakumar AV; Insinga RR; Bentley J; Escott N; Ghatage P; Koushik A; Ferenczy A; Franco EL
    J Med Virol; 2011 Jun; 83(6):1034-41. PubMed ID: 21503917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-risk human papillomavirus infection and cervical cytopathology: relationship with cervical nitric oxide levels.
    El-Wakil DM; Shaker OG; Rashwan ASSA; Elesawy YF; Samir N
    Virol J; 2024 Aug; 21(1):173. PubMed ID: 39095843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of HIV mRNA in routine liquid-based cytology specimens of HIV-infected women.
    Brito MJ; Quintas A; Sequeira P; Alves AT; Martins C; Félix A
    Cytopathology; 2021 Sep; 32(5):640-645. PubMed ID: 33914385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples.
    Song F; Du H; Wang C; Huang X; Wu R;
    PLoS One; 2020; 15(6):e0234518. PubMed ID: 32525936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China's top 3 hospital, 2009-2019.
    Liu Y; Ang Q; Wu H; Xu J; Chen D; Zhao H; Liu H; Guo X; Gu Y; Qiu H
    Virol J; 2020 Jul; 17(1):104. PubMed ID: 32660490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of cervical high-grade squamous intraepithelial lesions and squamous cell carcinoma in women with high-risk human papillomavirus and normal cervical cytology: A retrospective analysis of 1858 cases stratified by age and human papillomavirus genotype.
    Gu L; Hong Z; Gao H; Qiu L; Di W
    Cytopathology; 2019 Jul; 30(4):419-425. PubMed ID: 31069857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of cervical cytologic status on the association between human papillomavirus type 16 DNA load and the risk of cervical intraepithelial neoplasia grade 3.
    Xi LF; Kiviat NB; Galloway DA; Zhou XH; Ho J; Koutsky LA
    J Infect Dis; 2008 Aug; 198(3):324-31. PubMed ID: 18627250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of human papillomavirus type 16/18 genotyping in predicting high-grade cervical/vaginal intraepithelial neoplasm in women with mildly abnormal Papanicolaou results.
    Guo M; Gong Y; Wang J; Dawlett M; Patel S; Liu P; Bevers TB; Sneige N
    Cancer Cytopathol; 2013 Feb; 121(2):79-85. PubMed ID: 23225501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in DNA Level of Oncogenic Human Papillomaviruses Other Than Types 16 and 18 in Relation to Risk of Cervical Intraepithelial Neoplasia Grades 2 and 3.
    Xi LF; Schiffman M; Hughes JP; Galloway DA; Koutsky LA; Kiviat NB
    Cancer Epidemiol Biomarkers Prev; 2019 Aug; 28(8):1388-1394. PubMed ID: 31101617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early integration of high copy HPV16 detectable in women with normal and low grade cervical cytology and histology.
    Kulmala SM; Syrjänen SM; Gyllensten UB; Shabalova IP; Petrovichev N; Tosi P; Syrjänen KJ; Johansson BC
    J Clin Pathol; 2006 May; 59(5):513-7. PubMed ID: 16484445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of the diagnostic accuracy of testing for high-risk (HR) human papillomavirus (HPV) types 16, 18 and 45 in precancerous cervical lesions: preliminary data.
    Tiews S; Steinberg W; Schneider W; Hanrath C
    J Clin Virol; 2009 Nov; 46 Suppl 3():S11-5. PubMed ID: 20129068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human papillomavirus types 16 and 18 DNA load in relation to coexistence of other types, particularly those in the same species.
    Xi LF; Edelstein ZR; Meyers C; Ho J; Cherne SL; Schiffman M
    Cancer Epidemiol Biomarkers Prev; 2009 Sep; 18(9):2507-12. PubMed ID: 19690188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.